Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302], an innovation led company, has agreed to acquire Decision Resources Group a US based company in the healthcare information segment, from Providence Equity Partners for a consideration of ...
read more
ICON plc has made the following appointments:
Dr. Susan Anton, Director, Epidemiology and Risk Management Practice, ICON Late Phase & Outcomes Research
Dr. Susan Anton comes to ICON with over 25 years of experience leading international ...
read more
AMRI, a leading global contract research and manufacturing organization, announced today the appointment of Ian Shott as President of AMRI Europe, reporting to Thomas D’Ambra, Ph.D., chairman, president and CEO. In this newly created role, Mr. Shott ...
read more
The company earmarks new EUR 90 million loan facility for further acquisition of niche CDMOs, investment in existing facilities and building long term partnerships with major pharmaceuticals companies.
read more
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its participation at the International Society for Pharmacoeconomics and Outcomes Research (...
read more
Marken announced today that it has opened its first office in South Korea. The office will manage customer service operations and offer local service to its customers who currently operate in the South Korea. Marken currently operates in the ...
read more
Dr. Parks, currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM N.V. (NYSE, Euronext: DSM KON), has been appointed President and Business Unit Director of DSM Pharmaceuticals, Inc, as of...
read more
Norwich focuses on manufacturing potent, solid dose products, including fast dissolve and controlled release tablets, while also providing a range of analytical services in-house.
read more
PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that industry veteran ...
read more
Aceto Corporation (Nasdaq:ACET), a global leader in the marketing, sales and distribution of pharmaceutical active ingredients and intermediates, finished dosage form generic pharmaceuticals, nutraceutical products, agricultural protection products ...
read more
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization specializing in the development of difficult to formulate compounds, announced today that it has made a grant to the University of Mississippi (UM). The ...
read more
Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will address topics including observational data methods, commercialization, and coverage policy during the International Society for...
read more
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, including storage, cold chain logistics and virtual sample intelligence, has announced the appointment of Kristina Robson, Ph.D., as ...
read more
Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a payment of EUR 4.0 million to Evotec. The milestone was for the transition of a respiratory programme into pre-clinical development.
read more
IGI Laboratories, Inc., a New Jersey based formulation and manufacturing company, today announced that it has submitted an additional abbreviated new drug application (ANDA) to the US FDA, bringing the company’s total number of submissions to six.
read more